The inflammatory pathogenetic pathways of Fabry nephropathy
- Autores
- Feriozzi. Sandro; Rozenfeld, Paula Adriana
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The high variability in clinical features and outcomes observed in monogenic diseases like Fabry disease suggeststhe presence of additional pathogenetic pathways beyond the lysosomal deposition of Gb3 and Lyso-GB3.Research indicates that the deposition of Gb3 and Lyso-Gb3 can stimulate the inflammatory processes.Mononuclear immune-competent cells exposed to Gb3 deposition exhibit surface adhesion molecules and releasepro-inflammatory and fibrotic cytokines such as IL β, TNFα, and TGFβ, culminating in the activation ofinflammatory cascades associated with oxidative stress, apoptotic mechanisms maintained by renal residents andinfiltrating cells, leading to chronic inflammation and tissue fibrosis. Furthermore, in another avenue of inquiry(termed Agalopathy), the mutated galactosidase alpha gene can result in the production of an altered alphagalactosidaseA enzyme, inducing endoplasmic reticulum stress and triggering the unfolded protein response(UPR) in an effort to prevent the production of altered proteins. The UPR, in turn, instigates the release of proinflammatorycytokines, thereby contributing to the inflammatory milieu. Experimental findings have demonstratedthat the pathogenetic mechanisms activated by Gb3 and Lyso Gb3 deposition can become independent from theinitial stimulus and may exhibit limited responsiveness to therapy. Cellular pathway alterations can persist posttherapyor gene correction. Moreover, biochemical and histological lesions characteristic of Fabry disease manifestin the absence of Gb3 in the Zebrafish experimental model. This review endeavors to describe the role of theseprocesses in Fabry nephropathy and aims to synthesize the available evidence on the pathogenesis of renaldamage.
Fil: Feriozzi. Sandro. Belcolle Hospital; Italia
Fil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Estudios Inmunológicos y Fisiopatológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Estudios Inmunológicos y Fisiopatológicos; Argentina - Materia
-
FABRY HEPHROPATHY
INFLAMMATION
PATHOGENETIC MEHCANISMS
FABRY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/257383
Ver los metadatos del registro completo
id |
CONICETDig_21cb929fd74f9b22f8eb351cda53a29c |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/257383 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
The inflammatory pathogenetic pathways of Fabry nephropathyFeriozzi. SandroRozenfeld, Paula AdrianaFABRY HEPHROPATHYINFLAMMATIONPATHOGENETIC MEHCANISMSFABRYhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The high variability in clinical features and outcomes observed in monogenic diseases like Fabry disease suggeststhe presence of additional pathogenetic pathways beyond the lysosomal deposition of Gb3 and Lyso-GB3.Research indicates that the deposition of Gb3 and Lyso-Gb3 can stimulate the inflammatory processes.Mononuclear immune-competent cells exposed to Gb3 deposition exhibit surface adhesion molecules and releasepro-inflammatory and fibrotic cytokines such as IL β, TNFα, and TGFβ, culminating in the activation ofinflammatory cascades associated with oxidative stress, apoptotic mechanisms maintained by renal residents andinfiltrating cells, leading to chronic inflammation and tissue fibrosis. Furthermore, in another avenue of inquiry(termed Agalopathy), the mutated galactosidase alpha gene can result in the production of an altered alphagalactosidaseA enzyme, inducing endoplasmic reticulum stress and triggering the unfolded protein response(UPR) in an effort to prevent the production of altered proteins. The UPR, in turn, instigates the release of proinflammatorycytokines, thereby contributing to the inflammatory milieu. Experimental findings have demonstratedthat the pathogenetic mechanisms activated by Gb3 and Lyso Gb3 deposition can become independent from theinitial stimulus and may exhibit limited responsiveness to therapy. Cellular pathway alterations can persist posttherapyor gene correction. Moreover, biochemical and histological lesions characteristic of Fabry disease manifestin the absence of Gb3 in the Zebrafish experimental model. This review endeavors to describe the role of theseprocesses in Fabry nephropathy and aims to synthesize the available evidence on the pathogenesis of renaldamage.Fil: Feriozzi. Sandro. Belcolle Hospital; ItaliaFil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Estudios Inmunológicos y Fisiopatológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Estudios Inmunológicos y Fisiopatológicos; ArgentinaOAE Publishing Inc2024-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/257383Feriozzi. Sandro; Rozenfeld, Paula Adriana; The inflammatory pathogenetic pathways of Fabry nephropathy; OAE Publishing Inc; Rare Disease and Orphan Drugs Journal; 12-2024; 1-112771-2893CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.oaepublish.com/articles/rdodj.2023.37info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:52:31Zoai:ri.conicet.gov.ar:11336/257383instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:52:31.883CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
The inflammatory pathogenetic pathways of Fabry nephropathy |
title |
The inflammatory pathogenetic pathways of Fabry nephropathy |
spellingShingle |
The inflammatory pathogenetic pathways of Fabry nephropathy Feriozzi. Sandro FABRY HEPHROPATHY INFLAMMATION PATHOGENETIC MEHCANISMS FABRY |
title_short |
The inflammatory pathogenetic pathways of Fabry nephropathy |
title_full |
The inflammatory pathogenetic pathways of Fabry nephropathy |
title_fullStr |
The inflammatory pathogenetic pathways of Fabry nephropathy |
title_full_unstemmed |
The inflammatory pathogenetic pathways of Fabry nephropathy |
title_sort |
The inflammatory pathogenetic pathways of Fabry nephropathy |
dc.creator.none.fl_str_mv |
Feriozzi. Sandro Rozenfeld, Paula Adriana |
author |
Feriozzi. Sandro |
author_facet |
Feriozzi. Sandro Rozenfeld, Paula Adriana |
author_role |
author |
author2 |
Rozenfeld, Paula Adriana |
author2_role |
author |
dc.subject.none.fl_str_mv |
FABRY HEPHROPATHY INFLAMMATION PATHOGENETIC MEHCANISMS FABRY |
topic |
FABRY HEPHROPATHY INFLAMMATION PATHOGENETIC MEHCANISMS FABRY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The high variability in clinical features and outcomes observed in monogenic diseases like Fabry disease suggeststhe presence of additional pathogenetic pathways beyond the lysosomal deposition of Gb3 and Lyso-GB3.Research indicates that the deposition of Gb3 and Lyso-Gb3 can stimulate the inflammatory processes.Mononuclear immune-competent cells exposed to Gb3 deposition exhibit surface adhesion molecules and releasepro-inflammatory and fibrotic cytokines such as IL β, TNFα, and TGFβ, culminating in the activation ofinflammatory cascades associated with oxidative stress, apoptotic mechanisms maintained by renal residents andinfiltrating cells, leading to chronic inflammation and tissue fibrosis. Furthermore, in another avenue of inquiry(termed Agalopathy), the mutated galactosidase alpha gene can result in the production of an altered alphagalactosidaseA enzyme, inducing endoplasmic reticulum stress and triggering the unfolded protein response(UPR) in an effort to prevent the production of altered proteins. The UPR, in turn, instigates the release of proinflammatorycytokines, thereby contributing to the inflammatory milieu. Experimental findings have demonstratedthat the pathogenetic mechanisms activated by Gb3 and Lyso Gb3 deposition can become independent from theinitial stimulus and may exhibit limited responsiveness to therapy. Cellular pathway alterations can persist posttherapyor gene correction. Moreover, biochemical and histological lesions characteristic of Fabry disease manifestin the absence of Gb3 in the Zebrafish experimental model. This review endeavors to describe the role of theseprocesses in Fabry nephropathy and aims to synthesize the available evidence on the pathogenesis of renaldamage. Fil: Feriozzi. Sandro. Belcolle Hospital; Italia Fil: Rozenfeld, Paula Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Estudios Inmunológicos y Fisiopatológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Estudios Inmunológicos y Fisiopatológicos; Argentina |
description |
The high variability in clinical features and outcomes observed in monogenic diseases like Fabry disease suggeststhe presence of additional pathogenetic pathways beyond the lysosomal deposition of Gb3 and Lyso-GB3.Research indicates that the deposition of Gb3 and Lyso-Gb3 can stimulate the inflammatory processes.Mononuclear immune-competent cells exposed to Gb3 deposition exhibit surface adhesion molecules and releasepro-inflammatory and fibrotic cytokines such as IL β, TNFα, and TGFβ, culminating in the activation ofinflammatory cascades associated with oxidative stress, apoptotic mechanisms maintained by renal residents andinfiltrating cells, leading to chronic inflammation and tissue fibrosis. Furthermore, in another avenue of inquiry(termed Agalopathy), the mutated galactosidase alpha gene can result in the production of an altered alphagalactosidaseA enzyme, inducing endoplasmic reticulum stress and triggering the unfolded protein response(UPR) in an effort to prevent the production of altered proteins. The UPR, in turn, instigates the release of proinflammatorycytokines, thereby contributing to the inflammatory milieu. Experimental findings have demonstratedthat the pathogenetic mechanisms activated by Gb3 and Lyso Gb3 deposition can become independent from theinitial stimulus and may exhibit limited responsiveness to therapy. Cellular pathway alterations can persist posttherapyor gene correction. Moreover, biochemical and histological lesions characteristic of Fabry disease manifestin the absence of Gb3 in the Zebrafish experimental model. This review endeavors to describe the role of theseprocesses in Fabry nephropathy and aims to synthesize the available evidence on the pathogenesis of renaldamage. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/257383 Feriozzi. Sandro; Rozenfeld, Paula Adriana; The inflammatory pathogenetic pathways of Fabry nephropathy; OAE Publishing Inc; Rare Disease and Orphan Drugs Journal; 12-2024; 1-11 2771-2893 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/257383 |
identifier_str_mv |
Feriozzi. Sandro; Rozenfeld, Paula Adriana; The inflammatory pathogenetic pathways of Fabry nephropathy; OAE Publishing Inc; Rare Disease and Orphan Drugs Journal; 12-2024; 1-11 2771-2893 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.oaepublish.com/articles/rdodj.2023.37 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
OAE Publishing Inc |
publisher.none.fl_str_mv |
OAE Publishing Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269165096796160 |
score |
13.13397 |